Navigation Links
New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies
Date:12/18/2007

x in patients with inhalational anthrax disease in the event of an emergency prior to FDA licensure.

About Anthrax

Anthrax infection is caused by a spore-forming bacterium, Bacillus anthracis, which multiplies in the body and produces lethal toxins. Most anthrax fatalities are caused by the irreversible effects of the anthrax toxins. Research has shown that the bacteria produce protective antigen, the key facilitator in the progression of anthrax infection at the cellular level. After protective antigen and the anthrax toxins are produced by the bacteria, protective antigen binds to the anthrax toxin receptor on cell surfaces and forms a protein-receptor complex that makes it possible for the anthrax toxins to enter the cells. ABthrax blocks the binding of protective antigen to cell surfaces and prevents the anthrax toxins from entering and killing the cells.

About Human Genome Sciences

The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs.

The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, anthrax disease, cancer and other immune-mediated diseases. The Company's primary focus is rapid progress toward the commercialization of its two key lead drugs, Albuferon(R) (albinterferon alfa- 2b) for hepatitis C and LymphoStat-B(R) (belimumab) for lupus. Phase 3 clinical trials of both drugs are ongoing. ABthrax (raxibacumab) is in late- stage development for the treatment of anthrax disease. Other HGS drugs in clinical development include two TRAIL receptor antibodies for the treatment of cancers.

For more information about HGS, please visit the Company's web site at http://www.hgsi.com. For more information about ABthrax, please visit http://www.hgsi.com/products/ABthrax.html. Health professionals or patients
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Study Demonstrates Mindful Approach to Aging
2. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty
3. Raydiance Collaborates With Rutgers University and Nations Largest Tissue Bank to Develop Innovative Tissue Processing Approaches
4. Endoscopy Identified as Safe and Effective Method in Treating Common Complication of Gastric Bypass Surgery
5. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
6. New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients With Complicated Skin Infections, Including MRSA
7. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
8. Promising Results in Treating Facial Bruising From Injectables
9. Evidence of Benefit Lacking for Many Common Ways of Treating Osteoarthritis of the Knee
10. New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients with Diabetic Foot Infections
11. Edwards Resilient Trial Demonstrates Statistically Superior Results for Treating Peripheral Arterial Disease in the Leg
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015  Cleveland Clinic President ... keynote address last month that industry is compelled to ... to gain the efficiencies—and develop the transformational innovations -- ... Barsoum,s comments were preceded by Doug Kohrs , ... OMTEC moderator, who stressed that industry must add "episode ...
(Date:7/30/2015)... FAIRFIELD, N.J. , July 30, 2015 /PRNewswire/ ... Ferrer, completed the second Phase III clinical study ... development for impetigo.  Medimetriks owns the exclusive U.S. ... The global trial, conducted at 44 centers with ... and pediatric patients aged 2 months and older ...
(Date:7/30/2015)... Calif. , July 30, 2015   ... to eliminate all preventable hospitalization, recently received confirmation ... its Remote Patient Intelligence (RPI) solution meets the ... FDA intends to exercise "Enforcement Discretion." ... not subject to further FDA regulatory requirements at ...
Breaking Medicine Technology:Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 3FDA Clears Way for Commercial Marketing of Sentrian Remote Patient Intelligence Solution 2FDA Clears Way for Commercial Marketing of Sentrian Remote Patient Intelligence Solution 3
(Date:7/30/2015)... ... July 30, 2015 , ... Dale Sky Jones, Executive Chancellor of ... the International Cannabis Professionals Expo held at the Caribe Royal All Suites Hotel and ... Professionals Expo is the largest medical cannabis expo in the country and this ...
(Date:7/30/2015)... ... 31, 2015 , ... The Venetian on Grace Bay in the Turks & Caicos Islands is ... Venetian will save 40% on their stay while enjoying some of the most beautiful ocean ... & Caicos, providing a chance to reconnect with loved ones and rediscover one's best self. ...
(Date:7/30/2015)... ... July 31, 2015 , ... Committed to helping the ... by asking community members to contribute to the College’s “My Brother’s Keeper Scholarship.” The ... young people stay on track. Providing the support they need to think more broadly ...
(Date:7/30/2015)... Sierra Madre, CA (PRWEB) , ... July 30, 2015 , ... ... wound care programs, the activity of recruiting patients becomes a serious challenge. Because of ... wound care program to patients within the local community. , The team at ...
(Date:7/30/2015)... ... July 30, 2015 , ... OSF Healthcare System has been ... Most Wired Survey conducted by Hospitals & Health Networks. This marks the fourth consecutive ... by The Sisters of the Third Order of St. Francis . , Health ...
Breaking Medicine News(10 mins):Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 2Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 3Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 4Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 5Health News:The Venetian on Grace Bay in Turks & Caicos Islands Offers 40% Savings This Fall. 2Health News:Mercy College a “My Brother’s Keeper” Community 2Health News:Mercy College a “My Brother’s Keeper” Community 3Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 2Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 3Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 4Health News:OSF HealthCare Named One of the Most Wired Systems 2Health News:OSF HealthCare Named One of the Most Wired Systems 3
... Cytori Therapeutics (NASDAQ: CYTX) announced today the ... European Journal of Surgical Oncology. , ... trial using autologous adipose-derived regenerative cell (ADRC)-enriched fat ... surgery. The majority of patients underwent radiation prior ...
... sudden hearing loss, a frightening condition that sends thousands in ... this month in the journal OtolaryngologyHead and Neck Surgery ... led by Robert J. Stachler, M.D., an otolaryngologist in the ... in Detroit. "In most cases, patients will have ...
... , MONDAY, March 19 (HealthDay News) -- The emergency room ... blackouts can be more than half a million dollars a ... new study found. The University of Wisconsin-Madison ... the 28 days before the start of the study, male ...
... of Granada researchers have developed a software tool that ... person has to suffer a heart disease. In addition, ... estimations, i.e. it helps estimating the risk that a ... The researchers employed a sample including 3 000 patients. ...
... March 17 (HealthDay News) -- People who follow seven ... die than those who follow few or none of ... 45,000 U.S. adults. However, the researchers also found ... recommended by the American Heart Association (AHA), which include: ...
... 17 (HealthDay News) -- Teens and young adults who binge ... be risking brain damage, an expert warns. Binge drinking, ... drinks by males and three drinks by females in a ... said Dr. Alicia Ann Kowalchuk, medical director of the InSight ...
Cached Medicine News:Health News:Cytori breast reconstruction cell therapy trial results published 2Health News:First national guideline for sudden hearing loss published 2Health News:Excessive Drinking Costs U.S. Colleges Millions Annually 2Health News:Scientists develop a software tool for estimating heart disease risk 2Health News:Following Heart-Healthy Behaviors May Lengthen Your Life 2Health News:Following Heart-Healthy Behaviors May Lengthen Your Life 3Health News:Spring Break Boozing May Put Young Brains at Risk 2
Minimal M9CA Broth...
An agent used for making solid microbiological media....
... of miniTHERM incubators is available, ensuring the ... for their specific requirements. miniTHERM incubators have ... and extremely space saving. Their size corresponds ... is possible to stack up to three ...
In microbiological laboratories and for in vitro fertilization, as well as in cancer research or tissue engineering, the Heraeus CO2 incubator BBD 6220 provides the best contamination protection and ...
Medicine Products: